NiSource Other Non-Current Liabilities increased by 12.2% to $289.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 14.0%, from $336.70M to $289.60M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows a downward trend with a -12.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $566.80M | $527.40M | $690.20M | $669.50M | $329.70M | $288.50M | $296.80M | $298.50M | $294.60M | $291.50M | $298.60M | $297.70M | $308.30M | $311.80M | $313.00M | $336.70M | $344.40M | $337.40M | $258.00M | $289.60M |
| QoQ Change | — | -7.0% | +30.9% | -3.0% | -50.8% | -12.5% | +2.9% | +0.6% | -1.3% | -1.1% | +2.4% | -0.3% | +3.6% | +1.1% | +0.4% | +7.6% | +2.3% | -2.0% | -23.5% | +12.2% |
| YoY Change | — | — | — | — | -41.8% | -45.3% | -57.0% | -55.4% | -10.6% | +1.0% | +0.6% | -0.3% | +4.7% | +7.0% | +4.8% | +13.1% | +11.7% | +8.2% | -17.6% | -14.0% |